Indefinite Delivery Contract SPE2DX15D9517

This federal contract IDV award is held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $499,999,999, is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

Through this IDC and associated delivery orders, DMS Pharmaceutical Group provides direct distribution of a diverse array of pharmaceutical items, such as Xolair, Trikafta, Keytruda, Botox, Nucala, and various other specialized medications, as well as a broad portfolio of other prescription drugs and medical supplies. The contracts are not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure these direct federal awards across multiple product categories and medical domains. The period of performance for the IDC runs through November 2026, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.